Clinical Trial Update: MSC EVs in Dystrophic Epidermolysis Bullosa [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is investigating mesenchymal stem cell-derived extracellular vesicles (MSC EVs) for dystrophic epidermolysis bullosa. Recruitment is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dystrophic Epidermolysis Bullosa

Drugs mentioned

• MSC extracellular vesicles (mesenchymal stem cell-derived extracellular vesicles)

Snippet

Sponsor: Aegle Therapeutics | Conditions: Dystrophic Epidermolysis Bullosa | Phase 1, Phase 2 | Status: RECRUITING